Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 2

Autoimmune destruction of pericytes as the cause of diabetic retinopathy

Authors Duncan D Adams

Published 6 June 2008 Volume 2008:2(2) Pages 295—298


Duncan D Adams

Faculty of Medicine, University of Otago, Dunedin, New Zealand

Abstract: In diabetic retinopathy, collapse of the retinal vasculature is associated with loss of the pericytes. These are contractile cells that together with endothelial cells form the terminal arterioles of the retina. The cause of the loss of pericytes is not known. Recently, it has been discovered that type 1 diabetes is caused by forbidden clones of cytotoxic T lymphocytes, which destroy the insulin-making cells with exquisite specificity. In the light of this, I postulate that an antigenically-related forbidden clone of cytotoxic T lymphocytes selectively destroys the pericytes and that this is the cause of the vascular collapse of diabetic retinopathy. If this is so, the therapeutic implications are immense, involving a switch from ineffectual tight glycemic control to immunotherapy. This is already used as immunosuppression to prevent organ transplant rejection, and as the immune ablation and autologous bone marrow cell reconstitution that has saved the lives of patients with lethally-severe scleroderma. Once the pericyte surface auto-antigen for the T lymphocytes has been isolated, selective destruction of the pathogenic T lymphocytes would be possible by manufacture and use of cytotoxic auto-antigen complexes, which arrests progression of the retinopathy.

Keywords: pericytes, diabetic retinopathy, autoimmunity, T cell forbidden clones, immunotherapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Pars plana vitrectomy for malignant glaucoma in nonglaucomatous and in filtered glaucomatous eyes

Matlach J, Slobodda J, Grehn F, Klink T

Clinical Ophthalmology 2012, 6:1959-1966

Published Date: 27 November 2012

A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model

Melissa E Sanders, Erin W Norcross, Quincy C Moore III, Chinwendu Onwubiko, Lauren B King, et al

Clinical Ophthalmology 2008, 2:793-800

Published Date: 5 December 2008

Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly

Adriana Lima Vallochi, Anna Carla Goldberg, Angela Falcai, Rajendranath Ramasawmy, Jorge Kalil, et al

Clinical Ophthalmology 2008, 2:837-848

Published Date: 5 December 2008

Impending central retinal vein occlusion associated with cilioretinal artery obstruction

Juliana Mantovani Bottós, Fabio Bom Aggio, Eduardo Dib, Michel Eid Farah

Clinical Ophthalmology 2008, 2:665-668

Published Date: 12 September 2008

Oriental oculopalpebral dimensions: Quantitative comparison between Orientals from Japan and Brazil

Rodrigo U Takahagi, Silvana A Schellini, Carlos R Padovani, Shinji Ideta, Nobutada Katori, Yasuhisa Nakamura

Clinical Ophthalmology 2008, 2:563-567

Published Date: 12 September 2008

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy

J Charles Henry, James H Peace, Jeanette A Stewart, William C Stewart

Clinical Ophthalmology 2008, 2:613-621

Published Date: 12 September 2008

Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial

Mauro Campos, Mariana Ávila, Anelise Wallau, Cristina Muccioli, Ana Luisa Höfling-Lima, Rubens Belfort Jr

Clinical Ophthalmology 2008, 2:331-338

Published Date: 6 June 2008

Can macular translocation be a satisfactory management of subfoveal choroidal neovascular membrane?

Árpád Bereczki, Zsolt Bíró

Clinical Ophthalmology 2008, 2:447-450

Published Date: 6 June 2008

Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy

Paul W Hardwig, Amila O Silva, Jose S Pulido

Clinical Ophthalmology 2008, 2:199-201

Published Date: 7 March 2008